CVS Health Corporation (CVS) - What Are Brokerages Thinking About This Stock?

Key Points

• Analysts hold a “Moderate Buy” consensus on CVS Health, with 19 buy ratings and three holds among 22 brokerages. The average 12-month price target is $109.64, implying upside from the reported $90.20 share price.
• CVS reported strong quarterly results, with earnings of $2.58 per share versus the $1.87 consensus estimate and revenue of $106.1 billion, up 7.3% year over year. Analysts forecast approximately $8.02 in EPS for the current year.
• The company declared a quarterly dividend of $0.665 per share, equivalent to a 2.9% annual yield and a 70.37% payout ratio; institutional investors and hedge funds own 80.66% of the stock.

CVS Health Corporation (NYSE:CVS - Get Free Report) has earned an average rating of "Moderate Buy" from the twenty-two brokerages that are currently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and nineteen have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $109.64.

CVS has been the subject of a number of analyst reports. Wells Fargo & Company boosted their price objective on CVS Health from $103.00 to $123.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Barclays increased their target price on CVS Health from $106.00 to $108.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Cantor Fitzgerald reiterated a "neutral" rating on shares of CVS Health in a research note on Friday, October 9th. JPMorgan Chase & Co. boosted their price target on shares of CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a report on Wednesday, August 12th. Finally, Leerink Partners lowered their price target on shares of CVS Health from $119.00 to $112.00 and set an "outperform" rating for the company in a research report on Monday, October 12th.

CVS Health Stock Down 0.1%

CVS stock opened at $90.20 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health has a 1-year low of $69.51 and a 1-year high of $110.68. The firm has a fifty day moving average price of $91.22 and a two-hundred day moving average price of $88.76. The firm has a market cap of $115.36 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 0.84 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period last year, the firm posted $1.81 EPS. The company's revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts predict that CVS Health will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be paid a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health's payout ratio is presently 70.37%.

Institutional Trading of CVS Health

Several large investors have recently added to or reduced their stakes in CVS. Kilter Group LLC bought a new stake in shares of CVS Health in the second quarter worth $27,000. Beaird Harris Wealth Management LLC boosted its position in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after acquiring an additional 195 shares in the last quarter. J.Safra Asset Management Corp bought a new position in shares of CVS Health in the 2nd quarter valued at $30,000. Timbuktu Capital Management LLC acquired a new position in CVS Health during the 2nd quarter worth approximately $31,000. Finally, Dunhill Financial LLC bought a new position in CVS Health in the second quarter valued at about $32,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation NYSE: CVS is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company's Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.